Trillium Therapeutics shares soar on Pfizer’s $2.26B deal
Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
Best Dslr Camera under 200 via FOX BUSINESS NEWS Markets
https://ift.tt/382GaOd
No comments:
Post a Comment